Dr Gregory J Cannarsa, MD - Medicare Neurological Surgery in Naples, FL

Dr Gregory J Cannarsa, MD is a medicare enrolled "Neurological Surgery" physician in Naples, Florida. His current practice location is 3530 Kraft Rd Ste 203, Naples, Florida. You can reach out to his office (for appointments etc.) via phone at (239) 422-2739.

Dr Gregory J Cannarsa is licensed to practice in Florida (license number ME158122) and he also participates in the medicare program. He does not accept medicare assignments directly but he may accept medicare through third-party (refer to Reassignment section below) and may also prescribe medicare part D drugs. His NPI Number is 1669866539.

Contact Information

Dr Gregory J Cannarsa, MD
3530 Kraft Rd Ste 203,
Naples, FL 34105-5020
(239) 422-2739
(239) 529-5695



Physician's Profile

Full NameDr Gregory J Cannarsa
GenderMale
SpecialityNeurological Surgery
Location3530 Kraft Rd Ste 203, Naples, Florida
Accepts Medicare AssignmentsMedicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs.
  NPI Data:
  • NPI Number: 1669866539
  • Provider Enumeration Date: 03/27/2015
  • Last Update Date: 08/02/2023
  Medicare PECOS Information:
  • PECOS PAC ID: 2769789544
  • Enrollment ID: I20220721003002

Medical Identifiers

Medical identifiers for Dr Gregory J Cannarsa such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1669866539NPI-NPPES
2213909MedicaidWA

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
207T00000XNeurological Surgery ME158122 (Florida)Primary

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Dr Gregory J Cannarsa allows following entities to bill medicare on his behalf.
Entity NameSwedish Health Services
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1689612954
PECOS PAC ID: 0244138196
Enrollment ID: O20031230000187

News Archive

Porvair and Suzhou Tianlong Bio to develop epigenetic analysis technologies

Porvair Sciences are teaming up with Suzhou Tianlong Bio Technology Co Ltd (China), together with Swansea University and Xi'an Jiaotong University in a collaborative project entitled, "Automating & Stratification of Epigenetics in Healthcare" that is part of the Innovate UK / Jiangsu Industrial Challenge Programme.

Adding leucine to diets improves insulin sensitivity, pre-diabetic condition and metabolic syndrome

A study led by researchers at the Joslin Diabetes Center suggests that adding the amino acid leucine to their diets may help those with pre-diabetes or metabolic syndrome.

Dysfunctions in blood vessels contribute to the development of chronic inflammatory bowel diseases

In Germany alone there are around 400,000 patients who suffer from chronic inflammatory bowel diseases. For the first time, researchers at Universitätsklinikum Erlangen have discovered that dysfunctions in blood vessels play a significant role in the development of such diseases.

Solutions to royalty stacking issues a top priority in pharmaceutical and biotechnology sectors

As new technologies are innovated in the pharmaceutical and biotechnology sectors, the number of fresh patents and related regulations is also on the rise.

Cell Therapeutics' pixantrone NDA: FDA postpones ODAC meeting due to severe weather conditions

Cell Therapeutics, Inc. ("CTI") (Nasdaq and MTA: CTIC) announced today that the United States Food and Drug Administration informed CTI that due to severe weather conditions in the Washington, D.C. area, the FDA is postponing the Oncologic Drugs Advisory Committee ("ODAC") meeting that was to be held on Wednesday, February 10, 2010 to discuss the pixantrone New Drug Application ("NDA"). The FDA indicated that it intends to reschedule the meeting as soon as the FDA can determine a schedule that will allow them to reconvene the advisory panel.

Read more Medical News

› Verified 8 days ago

Entity NameProvidence Health & Services- Washington
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1124270715
PECOS PAC ID: 8325100480
Enrollment ID: O20081224000111

News Archive

Porvair and Suzhou Tianlong Bio to develop epigenetic analysis technologies

Porvair Sciences are teaming up with Suzhou Tianlong Bio Technology Co Ltd (China), together with Swansea University and Xi'an Jiaotong University in a collaborative project entitled, "Automating & Stratification of Epigenetics in Healthcare" that is part of the Innovate UK / Jiangsu Industrial Challenge Programme.

Adding leucine to diets improves insulin sensitivity, pre-diabetic condition and metabolic syndrome

A study led by researchers at the Joslin Diabetes Center suggests that adding the amino acid leucine to their diets may help those with pre-diabetes or metabolic syndrome.

Dysfunctions in blood vessels contribute to the development of chronic inflammatory bowel diseases

In Germany alone there are around 400,000 patients who suffer from chronic inflammatory bowel diseases. For the first time, researchers at Universitätsklinikum Erlangen have discovered that dysfunctions in blood vessels play a significant role in the development of such diseases.

Solutions to royalty stacking issues a top priority in pharmaceutical and biotechnology sectors

As new technologies are innovated in the pharmaceutical and biotechnology sectors, the number of fresh patents and related regulations is also on the rise.

Cell Therapeutics' pixantrone NDA: FDA postpones ODAC meeting due to severe weather conditions

Cell Therapeutics, Inc. ("CTI") (Nasdaq and MTA: CTIC) announced today that the United States Food and Drug Administration informed CTI that due to severe weather conditions in the Washington, D.C. area, the FDA is postponing the Oncologic Drugs Advisory Committee ("ODAC") meeting that was to be held on Wednesday, February 10, 2010 to discuss the pixantrone New Drug Application ("NDA"). The FDA indicated that it intends to reschedule the meeting as soon as the FDA can determine a schedule that will allow them to reconvene the advisory panel.

Read more Medical News

› Verified 8 days ago

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Dr Gregory J Cannarsa is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Dr Gregory J Cannarsa, MD
3530 Kraft Rd Ste 203,
Naples, FL 34105-5020

Ph: (239) 422-2739
Dr Gregory J Cannarsa, MD
3530 Kraft Rd Ste 203,
Naples, FL 34105-5020

Ph: (239) 422-2739

News Archive

Porvair and Suzhou Tianlong Bio to develop epigenetic analysis technologies

Porvair Sciences are teaming up with Suzhou Tianlong Bio Technology Co Ltd (China), together with Swansea University and Xi'an Jiaotong University in a collaborative project entitled, "Automating & Stratification of Epigenetics in Healthcare" that is part of the Innovate UK / Jiangsu Industrial Challenge Programme.

Adding leucine to diets improves insulin sensitivity, pre-diabetic condition and metabolic syndrome

A study led by researchers at the Joslin Diabetes Center suggests that adding the amino acid leucine to their diets may help those with pre-diabetes or metabolic syndrome.

Dysfunctions in blood vessels contribute to the development of chronic inflammatory bowel diseases

In Germany alone there are around 400,000 patients who suffer from chronic inflammatory bowel diseases. For the first time, researchers at Universitätsklinikum Erlangen have discovered that dysfunctions in blood vessels play a significant role in the development of such diseases.

Solutions to royalty stacking issues a top priority in pharmaceutical and biotechnology sectors

As new technologies are innovated in the pharmaceutical and biotechnology sectors, the number of fresh patents and related regulations is also on the rise.

Cell Therapeutics' pixantrone NDA: FDA postpones ODAC meeting due to severe weather conditions

Cell Therapeutics, Inc. ("CTI") (Nasdaq and MTA: CTIC) announced today that the United States Food and Drug Administration informed CTI that due to severe weather conditions in the Washington, D.C. area, the FDA is postponing the Oncologic Drugs Advisory Committee ("ODAC") meeting that was to be held on Wednesday, February 10, 2010 to discuss the pixantrone New Drug Application ("NDA"). The FDA indicated that it intends to reschedule the meeting as soon as the FDA can determine a schedule that will allow them to reconvene the advisory panel.

Read more News

› Verified 8 days ago


Neurological Surgery Doctors in Naples, FL

Dr. Michelle Carnes, DVM, DACVIM
Neurological Surgery
Medicare: Not Enrolled in Medicare
Practice Location: 2575 Northbrooke Plaza Dr Unit 100, Naples, FL 34119
Phone: 239-500-7226    
Dr. Christopher Joseph Pham, DO
Neurological Surgery
Medicare: May Accept Medicare Assignments
Practice Location: 2515 Northbrooke Plaza Dr, Suite 200, Naples, FL 34119
Phone: 239-325-9278    Fax: 239-325-9268
Dr. Mark Benjamin Frenkel, M.D.
Neurological Surgery
Medicare: Accepting Medicare Assignments
Practice Location: 6101 Pine Ridge Rd Ste 101, Naples, FL 34119
Phone: --    
Dr. Amanda Nicole Sacino, MD-PHD
Neurological Surgery
Medicare: Medicare Enrolled
Practice Location: 3530 Kraft Rd Ste 203, Naples, FL 34105
Phone: 239-422-2739    
Benjamin Jared Ditty, M.D.
Neurological Surgery
Medicare: Accepting Medicare Assignments
Practice Location: 877 111th Ave N Ste 1, Naples, FL 34108
Phone: 239-594-8002    Fax: 877-334-1886
Paul David Dernbach, ME
Neurological Surgery
Medicare: Not Enrolled in Medicare
Practice Location: 730 Goodlette Rd N, Suite 100, Naples, FL 34102
Phone: 239-262-1721    Fax: 236-262-1045
Dr. Mark B Gerber, M.D.
Neurological Surgery
Medicare: Accepting Medicare Assignments
Practice Location: 6101 Pine Ridge Rd Ste 101, Naples, FL 34119
Phone: 239-649-1662    Fax: 877-812-5411

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.